CLINICAL EFFICACY OF RECOMBINANT FACTOR VIII FC FUSION PROTEIN IN HAEMOPHILIA A PATIENT RECEIVING ON DEMAND TREATMENT ONLY by Saima Zahir, Tahira Zafar, Altaf Hussain, Hamid Saeed Malik, Pervez Ahmed, Saleem Ahmed Khan

Subjects: Get full text

[Use of Kovaltry® in patients with Hemophilia A: clinical and economical aspects from the pivotal clinical trials] by Lucia Sara D'Angiolella, Angelo Claudio Molinari, Paolo Angelo Cortesi, Antonio Coppola, Lorenzo Giovanni Mantovani

Subjects: Get full text

Comparative evaluation of the safety and efficacy of recombinant FVIII in severe hemophilia A patients by Hassan Abolghasemi, MD, Yunes Panahi, PhD, Minoo. Ahmadinejad, MD, Gholamreza Toogeh, MD, Mehran Karimi, MD, Aziz Eghbali, MD, Nargess Bigom Mirbehbahani, MD, Bighan Keikhaei Dehdezi, MD, Zahra Badiee, MD, Hamid Hoorfar, MD, Peyman Eshghi, MD, Nader Maghsoudi, PhD, Amirhossein Sahebkar, PhD, Mohammad Gholami- Fesharaki, PhD

Subjects: Get full text

[Kovaltry® for the replacement therapy in patients with Hemophilia A] by Daniela Paola Roggeri, Alessio Colombo, Alessandro Roggeri

Subjects: Get full text

Critical Review of the Pivotal Studies of Four rFVIII Products for the Treatment of Hemophilia A Patients: The Role of Octocog Alfa by Matteo Nicola Dario Di Minno, Lucia D'Angiolella, Paolo Angelo Cortesi, Angelo Claudio Molinari, Lorenzo Giovanni Mantovani

Subjects: Get full text

Treatment of hemophilic arthropathy by immunomodulatory extracellular vesicle delivered by liposome hybrid nanoparticles by Dong Wang, Wenzhe Chen, Jiali Chen, Du He, Yanli Pan, Pinger Wang, Qinghe Zeng, Mancang Gu, Peijian Tong, Di Chen, Hongting Jin

Subjects: Get full text

Safety and Efficacy of Turoctocog Alfa in the Prevention and Treatment of Bleeding Episodes in Previously Treated Patients from China with Severe Hemophilia A: Results from the Gua... by Wu R, Sun J, Xu W, Hu Q, Li W, Xiao J, Yang F, Zeng X, Zeng Y, Zhou J, Matytsina I, Zhang S, Pluta M, Yang R

Subjects: Get full text

Surgical management of endometriosis in a severe Hemophilia A female patient and the role of transfusion medicine specialist: A case report with review of literature by Sanooja Pinki, Ganesh Mohan, Divya Venugopal, Susheela J Innah

Subjects: Get full text

Cost-effectiveness analysis of low-dose prophylaxis versus on-demand treatment for moderate-to-severe hemophilia A in India by Tulika Seth, Kapil Garg, Prakas Kumar Mandal, Anupam Datta, Shailendra Verma, Suresh Hanagavadi, Usha Rani Thota

Subjects: Get full text

Status of Recombinant Factor VIII Concentrate Treatment for Hemophilia A in Italy: Characteristics and Clinical Benefits by Mario Schiavoni, Mariasanta Napolitano, Gaetano Giuffrida, Antonella Coluccia, Sergio Siragusa, Valeria Calafiore, Giuseppe Lassandro, Paola Giordano

Subjects: Get full text

Effect of tertiary prophylaxis with low-dose factor VIII in quality of life in adult patients with severe hemophilia A by Prakas Kumar Mandal, Abhijit Phukan, Amrita Bhowmik, Debasis Gantait, Prantar Chakrabarti

Subjects: Get full text

A Prospective Observational Study of Antihemophilic Factor (Recombinant) Prophylaxis Related to Physical Activity Levels in Patients with Hemophilia A in the United States (SPACE) by Konkle BA, Quon DV, Raffini L, Recht M, Radulescu VC, Carpenter SL, Dunn AL, Lu M, Watt M

Subjects: Get full text

Treatment With Efmoroctocog Alfa (Elocta®) in Hemophilia: A Case Series by Ezio Zanon, Alberto Tosetto, Paolo Radossi, Samantha Pasca, Elisa Bonetti, Simone Cesaro, Anna Chiara Giuffrida

Subjects: Get full text

Matching-adjusted indirect comparisons of efficacy of BAY 81-8973 vs two recombinant factor VIII for the prophylactic treatment of severe hemophilia A by Pocoski J, Li N, Ayyagari R,Church N, Maas Enriquez M, Xiang Q, Kelkar S, Du EX, Wu EQ, Xie J

Subjects: Get full text

The inhibitors – a challenge for the management of patients with hereditary haemophilia A by Mihăilă Romeo-Gabriel

Subjects: Get full text

The F309S mutation increases factor VIII secretion in human cell line by Daianne Maciely Carvalho Fantacini, Aparecida Maria Fontes, Mário Soares de Abreu Neto, Dimas Tadeu Covas, Virgínia Picanço-Castro

Subjects: Get full text

Willingness to pay for eliminating the risk of being infected by blood-borne diseases in regular replacement treatment for patients with haemophilia by Sara Olofsson, Katarina Steen Carlsson, Erik Berntorp, Emmelie Persson, Flemming Axelsen, Ulf Persson

Subjects: Get full text

Tailored therapy with turoctocog alfa pegol according to patient’s lifestyle and hemorrhagic phenotype: from clinical trial to real-life by Ilaria Nichele, Giuseppe Carli, Alberto Tosetto

Subjects: Get full text

The Impact of Pharmacokinetic-Guided Prophylaxis on Clinical Outcomes and Healthcare Resource Utilization in Hemophilia A Patients: Real-World Evidence from the CHESS II Study by Ferri Grazzi E, Sun SX, Burke T, O'Hara J

Subjects: Get full text